D.E. Shaw & Co
CRSP icon

D.E. Shaw & Co’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Hold
0
3148
2025
Q1
Hold
0
3087
2024
Q4
Sell
-29,365
Closed -$1.38M 3074
2024
Q3
$1.38M Buy
29,365
+1,191
+4% +$56K ﹤0.01% 2006
2024
Q2
$1.52M Sell
28,174
-146,121
-84% -$7.89M ﹤0.01% 1978
2024
Q1
$11.9M Buy
174,295
+137,023
+368% +$9.34M 0.01% 841
2023
Q4
$2.33M Buy
+37,272
New +$2.33M ﹤0.01% 1662
2023
Q3
Hold
0
3095
2023
Q2
Sell
-4,600
Closed -$208K 3139
2023
Q1
$208K Sell
4,600
-9,300
-67% -$421K ﹤0.01% 2796
2022
Q4
$565K Buy
+13,900
New +$565K ﹤0.01% 2669
2022
Q3
Hold
0
3940
2022
Q2
Sell
-37,620
Closed -$2.36M 4193
2022
Q1
$2.36M Buy
37,620
+14,448
+62% +$907K ﹤0.01% 2317
2021
Q4
$1.76M Sell
23,172
-11,524
-33% -$873K ﹤0.01% 2451
2021
Q3
$3.88M Buy
34,696
+9,798
+39% +$1.1M ﹤0.01% 1653
2021
Q2
$4.03M Sell
24,898
-52,294
-68% -$8.47M ﹤0.01% 1570
2021
Q1
$9.41M Sell
77,192
-205,959
-73% -$25.1M 0.01% 1040
2020
Q4
$43.4M Buy
283,151
+16,284
+6% +$2.49M 0.04% 402
2020
Q3
$22.3M Sell
266,867
-61,757
-19% -$5.17M 0.02% 572
2020
Q2
$24.2M Buy
328,624
+52,765
+19% +$3.88M 0.03% 508
2020
Q1
$11.7M Buy
275,859
+267,192
+3,083% +$11.3M 0.02% 691
2019
Q4
$528K Sell
8,667
-11,417
-57% -$696K ﹤0.01% 2171
2019
Q3
$823K Buy
20,084
+13,065
+186% +$535K ﹤0.01% 1913
2019
Q2
$331K Buy
7,019
+467
+7% +$22K ﹤0.01% 2274
2019
Q1
$234K Sell
6,552
-18,160
-73% -$649K ﹤0.01% 2338
2018
Q4
$706K Buy
24,712
+19,177
+346% +$548K ﹤0.01% 1980
2018
Q3
$245K Sell
5,535
-152
-3% -$6.73K ﹤0.01% 2313
2018
Q2
$334K Sell
5,687
-10,308
-64% -$605K ﹤0.01% 2287
2018
Q1
$731K Buy
+15,995
New +$731K ﹤0.01% 1940